Clinical Trial

Evaluate the Efficacy and Safety of INI101 Compared to BOTOX® in Subjects With Moderate to Severe Glabellar Lines.

Name: Evaluate the Efficacy and Safety of INI101 Compared to BOTOX® in Subjects With Moderate to Severe Glabellar Lines. — clinical trial record (NCT07622004)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of botulinum toxin type A for injection INI101 compared to BOTOX® in subjects with moderate to severe glabellar lines.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-05-27.

Trial Details

NCT Number	NCT07622004
Lead Sponsor	INIBIO Co., Ltd.
Conditions	Glabellar Lines
Enrollment	292 participants
Start Date	2021-05-27
Primary Completion	2022-01-30 (estimated)
Study Completion	2022-03-05 (estimated)
Updated on ClinicalTrials.gov	2026-06-03